申请人:Incyte Corporation
公开号:US20210106588A1
公开(公告)日:2021-04-15
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR enzyme and are useful in the treatment of FGFR-associated diseases such as cancer.
这项发明涉及双环杂环化合物及其药物组合物,这些化合物是FGFR酶的抑制剂,可用于治疗与FGFR相关的疾病,如癌症。